{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-25-000034","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.471079+00:00","generated_at":"2026-05-17T00:07:25.939724+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ICU Medical Q3 revenue down 8.8% YoY; adjusted EPS improves to $2.03","bullets":["Q3 revenue $537M vs $589M YoY; GAAP net loss narrowed to $3.4M from $33M.","Adjusted diluted EPS $2.03 vs $1.59 YoY; adjusted EBITDA $105.9M vs $94.8M.","GAAP gross margin improved to 37% from 35% YoY.","Company updated fiscal year 2025 guidance; details in press release."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-25-000034","json":"https://secwatch.observer/filing/0000883984-25-000034.json","markdown":"https://secwatch.observer/filing/0000883984-25-000034.md","text":"https://secwatch.observer/filing/0000883984-25-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398425000034/0000883984-25-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398425000034/icui-20251106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:07:25.939724+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}